JOVIC, GORDANA
JOVIC, GORDANA
Universita' degli Studi di MILANO
Exact method for analysis after single-stage and two-stage phase II cancer clinical trial
2008 G. Jovic
Preoperative chemotherapy plus lapatinib or trastuzumab or both in HER2-positive operable breast cancer (CHERLOB Trial)
2008 V. Guarneri, A. Frassoldati, F. Piacentini, G. Jovic, S. Giovannelli, C. Oliva, P.F. Conte
Letrozole versus letrozole plus Lapatinib (GW572016) in hormone-sensitive, HER2-negative operable breast cancer : a double-blind, randomized, phase II study with biomarker evaluation (EGF109077-LAP107692/LETLOB)
2008 A. Frassoldati, V. Guarneri, F. Piacentini, G. Jovic, S. Giovannelli, C. Oliva, P.F. Conte
Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases : impact on patient management
2008 V. Guarneri, S. Giovannelli, G. Ficarra, S. Bettelli, A. Maiorana, F. Piacentini, E. Barbieri, M.V. Dieci, R. D'Amico, G. Jovic, P.F. Conte
Biomarker expression and survival after primary chemotherapy for breast cancer
2007 V. Guarneri, F. Piacentini, G. Jovic, A. Frassoldati, G. Ficarra, S. Giovannelli, M. Maur, F. Borghi, R. Vicini, P.F. Conte
Preliminary safety data of preoperative chemotherapy plus trastuzumab, lapatinib or both in HER2 positive operable breast cancer
2007 V. Guarneri, A. Frassoldati, F. Piacentini, K. Cagossi, L. Cavanna, A. Michelotti, G. Jovic, S. Giovannelli, G. Ficarra, C. Oliva, P.F. Conte
Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy
2007 F. Bertolini,C. Bengala,L. Losi,M. Pagano, F. Iachetta,C. Dealis,G. Jovic,R. Depenni,S. Zironi,A.M. Falchi,G. Luppi,P.F. Conte
Helicobacter pylori infection and chronic immune thrombocytopenic purpura: long-term results of bacterium eradication and association with bacterium virulence profiles.
2007 G. Emilia, M. Luppi, P. Zucchini, M. Morselli, L. Potenza, F. Forghieri, F. Volzone, G. Jovic, G. Leonardi, A. Donelli, G. Torelli
Prognostic value of Dworak grade of regression (GR) in patients with rectal carcinoma treated with preoperative radiochemotherapy
2006 L. Losi, G. Luppi, M. Gavioli, F. Iachetta, F. Bertolini, R. D'Amico, G. Jovic, F. Bertoni, A.M. Falchi, P. Conte